General Information of the Molecule (ID: Mol01333)
Name
hsa-let-7f-1 ,Homo sapiens
Synonyms
microRNA let-7f-1
    Click to Show/Hide
Molecule Type
Precursor miRNA
Gene Name
MIRLET7F1
Gene ID
406888
Location
chr9:94176347-94176433[+]
Sequence
UCAGAGUGAGGUAGUAGAUUGUAUAGUUGUGGGGUAGUGAUUUUACCCUGUUCAGGAGAU
AACUAUACAAUCUAUUGCCUUCCCUGA
    Click to Show/Hide
Ensembl ID
ENSG00000199072
HGNC ID
HGNC:31483
Precursor Accession
MI0000067
        Click to Show/Hide the Complete Species Lineage
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Type(s) of Resistant Mechanism of This Molecule
  EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
Click to Show/Hide the Full List of Drugs
Cisplatin
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
  Epigenetic Alteration of DNA, RNA or Protein (EADR) Click to Show/Hide
Disease Class: Medulloblastoma [ICD-11: 2A00.10] [2]
Resistant Disease Medulloblastoma [ICD-11: 2A00.10]
Resistant Drug Cisplatin
Molecule Alteration Expression
Down-regulation
Experimental Note Revealed Based on the Cell Line Data
Cell Pathway Regulation Cell apoptosis Inhibition hsa04210
Cell proliferation Activation hsa05200
In Vitro Model D425 cells Brain Homo sapiens (Human) CVCL_1275
UW228 cells Brain Homo sapiens (Human) CVCL_8585
Experiment for
Molecule Alteration
RT-PCR
Experiment for
Drug Resistance
MTS assay; TUNEL assay
Mechanism Description High-Mobility Group Box 1 (HMGB1) is a direct target of miR-let-7f-1. HMGB1 is a highly conserved nuclear protein that functions as a chromatin-binding factor that bends DNA and promotes access to transcriptional protein assemblies on specific DNA targets. Overexpression of HMGB1 in cells treated with pSP and cisplatin blocked SPARC-induced cisplatin resistance indicating that overexpression of miR-let-7f-1 and a reduction in HMGB1 protein levels result in cellular resistance to cisplatin in SPARC over expressed cells. Earlier studies demonstrated that HMGB1 functions as a regulator of the balance between autophagy and apoptosis.
Gemcitabine
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
  Epigenetic Alteration of DNA, RNA or Protein (EADR) Click to Show/Hide
Disease Class: Pancreatic ductal adenocarcinoma [ICD-11: 2C10.0] [3]
Resistant Disease Pancreatic ductal adenocarcinoma [ICD-11: 2C10.0]
Resistant Drug Gemcitabine
Molecule Alteration Expression
Down-regulation
Experimental Note Revealed Based on the Cell Line Data
Cell Pathway Regulation EMT Regulation N.A.
In Vitro Model PANC-1 cells Pancreas Homo sapiens (Human) CVCL_0480
AsPC-1 cells Pancreas Homo sapiens (Human) CVCL_0152
COLO357 cells Pancreas Homo sapiens (Human) CVCL_0221
BxPC-3 cells Pancreas Homo sapiens (Human) CVCL_0186
HPAC cells Pancreas Homo sapiens (Human) CVCL_3517
Experiment for
Molecule Alteration
RT-qPCR; Western blot; Immunofluorescence staining
Experiment for
Drug Resistance
WST-1 assay
Mechanism Description Differential expression of let-7 and miR-200 in gemcitabine-sensitive and resistant pancreatic cancer cells treated with B-DIM or G2535 tested by miRNA array. The expression of hsa-let-7f-1 is decreased in drug-resistant cells.
References
Ref 1 Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathwayMol Cancer Ther. 2014 May;13(5):1078-91. doi: 10.1158/1535-7163.MCT-13-0709. Epub 2014 Mar 14.
Ref 2 miR-let-7f-1 regulates SPARC mediated cisplatin resistance in medulloblastoma cells. Cell Signal. 2014 Oct;26(10):2193-201. doi: 10.1016/j.cellsig.2014.06.014. Epub 2014 Jul 8.
Ref 3 Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009 Aug 15;69(16):6704-12. doi: 10.1158/0008-5472.CAN-09-1298. Epub 2009 Aug 4.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.